CCL2, a product of mice early after systemic inflammatory response syndrome (SIRS), induces alternatively activated macrophages capable of impairing antibacterial resistance of SIRS mice

Journal of Leukocyte Biology

Volumn 76, Issue 2, 2004, Pages 368-373

  Tsuda, Yasuhiro ^a   Takahashi, Hitoshi ^a   Kobayashi, Makiko ^a,b   Hanafusa, Toshiaki ^c   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CCL2; Infectious complications; Neutrophils; SIRS

Indexed keywords

ANTIINFECTIVE AGENT; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; CECUM; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; INFECTION SENSITIVITY; MACROPHAGE ACTIVATION; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; MACROPHAGES; MICE; MICE, INBRED BALB C; PANCREATITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALIA; MURINAE;

EID: 3442888222     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203645     Document Type: Conference Paper

References (46)

1. Bone, B. C. (1996) Immunological dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125, 680-687.
2. Bone, B. C. (1997) Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. In Sepsis and Multiorgan Failure (A. M. Fein, E. M. Abraham, R. A. Balk, G. R. Bernard, B. C. Bone, D. R. Dantzker, M. P. Fink, eds.), Philadelphia, PA, Williams & Wilkins, 3-10.
3. Foex, B. A. (1999) Systemic responses to trauma. Br. Med. Bull. 55, 726-743.
4. Mollnes, T. E., Fosse, E. (1994) The complement system in trauma-related and ischemic tissue damage: a brief review. Shock 2, 301-310.
5. Piccolo, M. T., Wang, Y., Verbrugge, S., Warner, R. L., Sannomiya, P., Piccolo, N. S., Piccolo, M. S., Hugh, T. E., Ward, P. A., Till, G. O. (1999) Role of chemotactic factors in neutrophil activation after thermal injury in rats. Inflammation 23, 371-385.
6. Glauser, M. P. (2000) Pathophysiological basis of sepsis: considerations for future strategies of intervention. Crit. Care Med. 28, S4-S8.
7. Riedemann, N. C., Guo, R. F., Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524.
8. Mogaboam, C. M., Kunkel, S. L. (2003) The role of chemokines in linking innate and adaptive immunity. In Infectious Diseases: Innate Immunity, (B. A. B. Ezekowitz, J. A. Hoffmann, eds.), Totowa, NJ, Humana, 269-286.
9. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
10. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
11. Goerdt, S., Orfanos, C. E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
12. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
13. Sester, D. P., Stacey, K. J., Sweet, M. J., Beasley, S. J., Cronau, S. L., Hume, D. A. (1999) The actions of bacterial DNA on murine macrophages. J. Leukoc. Biol. 66, 542-548.
14. 2 in the macrophage antiviral response of inducible nitric-oxide synthase expression. J. Biol. Chem. 277, 38449-38455.
15. Woods, J., Lu, Q., Ceddia, M. A., Lowder, T. (2000) Exercise-induced modulation of macrophage function. Immunol. Cell Biol. 78, 545-553.
16. Orlikowsky, T., Wang, Z. Q., Dudhane, A., Horowitz, H., Conti, B., Hoffmann, M. (1996) The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-enriched and IFN-γ-deprived donor environment. J. Interferon Cytokine Res. 16, 957-962.
17. Takahashi, H., Tsuda, Y., Kobayashi, M., Herndon, D. N., Suzuki, F. (2004) Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit. Care Med., in press.
18. Shimizu, T., Shiratori, K., Sawada, T., Kobayashi, M., Hayashi, N., Saotome, H., Keith, J. C. (2000) Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 21, 134-140.
19. Van Laethem, J. L., Marchant, A., Delvaux, A., Goldman, M., Robberecht, P., Velu, T., Deviere, J. (1995) Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108, 1917-1922.
20. Kikuchi, Y., Shimosegawa, T., Satoh, A., Abe, R., Abe, T., Koizumi, M., Toyota, T. (1996) The role of nitric oxide in mouse cerulein-induced pancreatitis with and without lipopolysaccharide pretreatment. Pancreas 12, 68-75.
21. Baker, C. C., Chaudry, I. H., Gaines, H. O., Baue, A. E. (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94, 331-335.
22. Takahashi, H., Tashiro, T., Miyazaki, M., Kobayashi, M., Pollard, R. B., Suzuki, F. (2002) An essential role of macrophage inflammatory protein 1α/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukoc. Biol. 72, 1190-1197.
23. Kobayashi, M., Takahashi, H., Sanford, A. P., Herndon, D. N., Pollard, R. B., Suzuki, F. (2002) An increase in the susceptibility of burned patients to infectious complications due to impaired production of macrophage inflammatory protein 1α. J. Immunol. 169, 4460-4466.
24. Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., Nathan, C. (2001) Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123-1140.
25. Kaisho, T., Akira, S. (2002) Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589, 1-13.
26. Janeway Jr., C. A., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
27. O'Shea, J. J., Gadina, M., Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109, S121-S131.
28. 2 by human monocytes infected with Mycobacterium avium complex-modulation of cytokine expression. J. Infect. Dis. 174, 806-811.
29. Vazquez-Torres, A., Fang, F. C. (2001) Oxygen-dependent anti-Salmonella activity of macrophages. Trends Microbiol. 9, 29-33.
30. Thomson, L., Denicola, A., Radi, R. (2003) The trypanothione-thiol system in Trypanosoma cruzi as a key antioxidant mechanism against peroxynitrite-mediated cytotoxicity. Arch. Biochem. Biophys. 412, 55-64.
31. Oxenius, A., Martinic, M. M., Hengartner, H., Klenerman, P. (1999) CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73, 4120-4126.
32. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M1/M2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
33. Katakura, T., Miyazaki, M., Kobayashi, M., Hemdon, D. N., Suzuki, F. (2004) CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172, 1407-1413.
34. 1-Acid glycoprotein (AGP) stimulates resident macrophages to generate alternatively activated macrophages (AAMφ). Part I. Biological properties of AGP-induced AAMφ. FASEB J. 17, C160 (abstract 79.34).
35. Takahashi, H., Kobayashi, M., Tsuda, Y., Sanford, A. P., Mizazaki, M., Hemdon, D. N., Suzuki, F. (2003) Compensatory anti-inflammatory response syndrome (CARS) manifested in association with severe systemic inflammatory response syndrome (SIRS). FASEB J. 17, C49 (abstract 35.26).
36. Sallusto, F., Mackay, C. R., Lanzavecchia, A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620.
37. Gu, L., Tseng, S., Homer, B. M., Tam, C., Loda, M., Rollins, B. J. (2000) Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411.
38. Traynor, T. R., Herring, A. C., Dorf, M. E., Kuziel, W. A., Toews, G. B., Huffnagle, G. B. (2002) Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168, 4659-4666.
39. Kurihara, T., Warr, G., Loy, J., Bravo, R. (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186, 1757-1762.
40. Sarafi, M. N., Garcia-Zepeda, E. A., MacLean, J. A., Charo, I. F., Luster, A. D. (1997) Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185, 99-109.
41. Luster, A. D. (2002) The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14, 129-135.
42. Bone, R. C. (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24, 1125-1128.
43. Doughty, L., Carcillo, J. A., Kaplan, S., Janosky, J. (1998) The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 113, 1625-1631.
44. Boring, L., Charo, I. F., Rollins, B. J. (1999) MCP-1 in human disease. In Chemokines in Disease (C. A. Hebert, ed.), Totowa, NJ, Humana, 53-65.
45. Nakajima, H., Kobayashi, M., Pollard, R. B., Suzuki, F. (2001) Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J. Leukoc. Biol. 70, 374-380.
46. Furukawa, K., Kobayashi, M., Sasaki, H., Herndon, D. N., Pollard, R. B., Suzuki, F. (2002) Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit. Care Med. 30, 1419-1424.